CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 3, April 2012
146
AFRICA
2.
Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-
term follow-up of idiopathic chronic pericardial effusion.
N Engl J Med
1999;
341
(27): 2054–2059.
3.
Sochocky S. Chronic pericardial effusion.
S D J Med
1970;
23
(3): 9–14.
4.
García-Riego A, Cuiñas C, Vilanova JJ. Malignant pericardial effusion.
Acta Cytol
2001;
45
(4): 561–566.
5.
Szturmowicz M, Tomkowski W, Fijalkowska A, Burakowski J,
Sakowicz A, Filipecki S. The role of carcinoembryonic antigen (CEA)
and neuron-specific enolase (NSE) evaluation in pericardial fluid for
the recognition of malignant pericarditis.
Int J Biol Markers
1997;
12
(3): 96–101.
6.
Szturmowicz M, Tomkowski W, Fijalkowska A, Kupis W, Cie
ś
lik A,
et
al
. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial
fluid for the recognition of neoplastic pericarditis.
Int J Biol Markers
2005;
20
(1): 43–49.
7.
Pawlak-Cie
ś
lik A, Szturmowicz M, Fijałkowska A, Tomkowski W,
Kupis W,
et al
. Neoplastic pericarditis--the role of different diagnostic
procedures.
Pol Arch Med Wewn
2006;
115
(1): 37–44.
8.
Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P,
et al
. New
approaches in the diagnostic procedure of malignant pleural effusions.
Oncol Rep
2004;
12
(1): 79–83.
9.
Svenberg T. Carcinoembryonic antigen-like substances of human
bile. Isolation and partial characterization.
Int J Cancer
1976;
17
(5):
588–596.
10. Shitrit D, Zingerman B, Shitrit AB, Shlomi D, Kramer MR. Diagnostic
value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays
in pleural effusions: analysis of 116 cases and review of the literature.
Oncologist
2005;
10
(7): 501–507.
11. Ohuchi N, Sato S, Akimoto M, Taira Y, Matoba N,
et al.
The correla-
tion between the immunohistochemical expression of DF3 antigen
and serum CA15-3 in breast cancer patients.
Jpn J Surg
1991;
21
(2):
129–137.
12. Nicolini A, Anselmi L, Michelassi C, Carpi A. Prolonged survival
by ‘early’ salvage treatment of breast cancer patients: a retrospective
6-year study.
Br J Cancer
1997;
76
(8): 1106–1111.
13. Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-
Panadero F. Use of a panel of tumor markers (carcinoembryonic anti-
gen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19
fragments) in pleural fluid for the differential diagnosis of benign and
malignant effusions.
Chest
2004;
126
(6): 1757–1763.
14. Romero S, Fernández C, Arriero JM, Espasa A, Candela A,
et al
. CEA,
CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with
pleural effusions.
Eur Respir J
1996;
9
(1): 17–23.
15. Shimokata K, Totani Y, Nakanishi K, Yamamoto M, Hasegawa Y,
et al
.
Diagnostic value of cancer antigen 15-3 (CA15-3) detected by mono-
clonal antibodies (115D8 and DF3) in exudative pleural effusions.
Eur
Respir J
1988;
1
(4): 341–344.
16. Mezger J, Permanetter W, Gerbes AL, Wilmanns W, Lamerz R. Tumor
associated antigens in diagnosis of serous effusions.
J Clin Pathol
1988;
41
(6): 633–643.
17. Kandylis K, Vassilomanolakis M, Baziotis N, Papadimitriou A,
et al
.
Diagnostic significance of the tumor markers CEA, CA 15-3 and CA
125 in malignant effusions in breast cancer.
Ann Oncol
1990;
1
(6):
435–438.
18. Ammon A, Eiffert H, Reil S, Beyer JH, Droese M, Hiddemann W.
Tumor-associated antigens in effusions of malignant and benign origin.
Clin Investig
1993;
71
(6): 437–444.
19. Galve E, Garcia-Del-Castillo H, Evangelista A, Batlle J, Permanyer-
Miralda G, Soler-Soler J. Pericardial effusion in the course of myocar-
dial infarction: incidence, natural history, and clinical relevance.
Circulation
1986;
73
(2): 294–299.
20. Tatsuta M, Yamamura H, Yamamoto R, Ichii M, Iishi H, Noguchi S.
Carcinoembryonic antigens in the pericardial fluid of patients with
malignant pericarditis.
Oncology
1984;
41
(5): 328–330.
21. Koh KK, In HH, Lee KH, Kim EJ, Cho CH,
et al
. New scoring system
using tumor markers in diagnosing patients with moderate pericardial
effusions.
Int J Cardiol
1997;
61
(1): 5–13.
22. Lindgren J, Kuusela P, Hellström PE, Pettersson T, Klockars M. The
ovarian cancer associated antigen CA 125 in patients with pleural effu-
sions.
Eur J Cancer Clin Oncol
1988;
24
(4): 737–739.
23. Faggiano P, D’Aloia A, Brentana L, Bignotti T, Fiorina C,
et al.
Serum
levels of different tumor markers in patients with chronic heart failure.
Eur J Heart Fail
2005;
7
(1): 57–61.
24. Whiteside TL, Dekker A. Diagnostic significance of carcinoembryonic
antigen levels in serous effusions. Correlation with cytology.
Acta Cytol
1979;
23
(6): 443–448.
25. Seo T, Ikeda Y, Onaka H, Hayashi T, Kawaguchi K, Kotake C, Toda T,
Kobayashi K. Usefulness of serum CA125 measurement for monitoring
pericardial effusion.
Jpn Circ J
1993;
57
(6): 489–494.
